(Q36889714)
Statements
Which screening strategy should be offered to women with BRCA1 or BRCA2 mutations? A simulation of comparative cost-effectiveness (English)
K M Vermeulen
L Jansen
J C Oosterwijk
S Siesling
M D Dorrius
N Houssami
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference